ELISA: How It Detects HIV Antibodies and Its Role in Diagnosis
Enzyme-Linked Immunosorbent Assay (ELISA) is a cornerstone of HIV screening worldwide. It detects antibodies to HIV-1 and HIV-2 in serum/plasma, enabling early infection identification.
How ELISA Works for HIV Testing
- Antigen coating – Plates coated with recombinant HIV proteins (gp120, gp41).
- Sample addition – Diluted serum/plasma added; HIV antibodies bind antigens.
- Washing – Removes unbound substances.
- Secondary antibody – Enzyme-conjugated (e.g., HRP) binds captured antibodies.
- Substrate reaction – Chromogenic/fluorescent substrate yields measurable color change.
- Result interpretation – Optical density compared to cutoff; above threshold = positive (exposure to HIV).
ELISA is simple, sensitive, cost-effective. Positive ELISA is a screening result; confirmatory tests (Western blot, nucleic acid amplification) required for definitive diagnosis.
See CDC HIV testing guidelines for algorithms.
HIV & AIDS - Related Articles
- Thrush: Symptoms, Causes, and When to See a Doctor
- Black Death Treatments: A Look at Failed Medieval Remedies
- Understanding HIV Tests: Methods & What to Expect
- Crack Cocaine Use in HIV: Accelerated Disease Progression and Complications
- Howard Rollins: Cause of Death – Understanding His Passing
- HIV and Normal Blood Tests: Can HIV Still Be Present?
- PrEP for HIV Prevention: Mechanism, Effectiveness & Clinical Guidance
